These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23689565)
1. Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis. Li Y; Zhang W; Ren H; Wang W; Shi H; Li X; Chen X; Shen P; Wu X; Xie J; Chen N Contrib Nephrol; 2013; 181():31-40. PubMed ID: 23689565 [TBL] [Abstract][Full Text] [Related]
2. The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old. Van Pottelbergh G; Vaes B; Jadoul M; Matheï C; Wallemacq P; Degryse JM Arch Gerontol Geriatr; 2012; 54(3):e419-25. PubMed ID: 22265240 [TBL] [Abstract][Full Text] [Related]
3. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359 [TBL] [Abstract][Full Text] [Related]
5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ; Shaheen FA Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [TBL] [Abstract][Full Text] [Related]
6. [Prevalence of chronic kidney disease in Chinese hospitalized adult patients: investigation of 13,383 cases]. Wu XC; Liu BC; Wang YL; Wang B; Gao J; Zhang QJ; Zhu Y; Zhang XL; Yin LF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2672-6. PubMed ID: 18167241 [TBL] [Abstract][Full Text] [Related]
7. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients. Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713 [TBL] [Abstract][Full Text] [Related]
8. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain. Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034 [TBL] [Abstract][Full Text] [Related]
9. [Risk factors for anemia in the early stages of chronic kidney disease]. Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688 [TBL] [Abstract][Full Text] [Related]
10. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826 [TBL] [Abstract][Full Text] [Related]
11. Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations. Kumar N; Lindberg J; David K; Morris J; Menoyo J Am J Nephrol; 2009; 29(2):71-8. PubMed ID: 18689981 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)]. Verdalles U; García de Vinuesa S; Goicoechea M; Gómez Campderá F; Luño J Nefrologia; 2007; 27(3):320-8. PubMed ID: 17725451 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly. Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016 [TBL] [Abstract][Full Text] [Related]
14. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients. Mehrotra R J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266 [TBL] [Abstract][Full Text] [Related]
15. Relationship between serum phosphorus and the progression of advanced chronic kidney disease. Caravaca F; Villa J; García de Vinuesa E; Martínez del Viejo C; Martínez Gallardo R; Macías R; Ferreira F; Cerezo I; Hernández-Gallego R Nefrologia; 2011; 31(6):707-15. PubMed ID: 22130287 [TBL] [Abstract][Full Text] [Related]
16. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges. Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962 [TBL] [Abstract][Full Text] [Related]
17. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Coyne D; Acharya M; Qiu P; Abboud H; Batlle D; Rosansky S; Fadem S; Levine B; Williams L; Andress DL; Sprague SM Am J Kidney Dis; 2006 Feb; 47(2):263-76. PubMed ID: 16431255 [TBL] [Abstract][Full Text] [Related]